Trump Supports Medicare Drug Pricing

This is a U.S. news story, published by CNBC, that relates primarily to Donald Trump news.

U.S. news

For more U.S. news, you can click here:

more U.S. news

Donald Trump news

For more Donald Trump news, you can click here:

more Donald Trump news

News about health policy

For more health policy news, you can click here:

more health policy news

CNBC news

For more news from CNBC, you can click here:

more news from CNBC

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about health policy, you might also like this article about

Medicare drug price negotiations

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest lower prescription medicine costs news, drug prices news, news about health policy, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

drug negotiation process

CNBC

•

Health

Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma

Summary

Nutrition label

84% Informative

President Donald Trump likely won't do away with a process that allows Medicare to negotiate drug prices with manufacturers.

The negotiations are a key provision of Biden's Inflation Reduction Act , or IRA, that aims to lower prescription medicine costs for seniors and save the government nearly $100 billion in Medicare spending over the next decade .

The path he takes could have huge stakes for the prices 68 million Medicare beneficiaries in the U.S. pay for their medications.

Trump could influence whether Medicare 's initial price offer for a drug is closer to the ceiling price.

Major changes to the price negotiations are much less likely to occur, as they would require help from Congress .

It's unclear how Trump will approach the ongoing legal fight between manufacturers and the federal government over the Medicare program.

VR Score

Informative language

Neutral language

Article tone

semi-formal

Language

English

Language complexity